查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631528

合成小分子 API 市場規模、佔有率、趨勢分析報告：按製造商、應用、地區、細分市場預測，2025-2030 年

Synthetic Small Molecule API Market Size, Share & Trends Analysis Report By Manufacturer (In-house, Outsourced), By Application (Oncology, Pulmonology, CNS, Endocrinology), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

合成小分子 API 市場的成長與趨勢

根據 Grand View Research, Inc. 的新報告，全球合成小分子 API 市場規模預計將在 2030 年達到 2,574 億美元，2025-2030 年期間的複合年成長率為 5.6%。這是由全球對藥品和新型小分子藥物日益成長的需求所推動的。此外，小分子 API 在劑型方面更加靈活，且更易於精製，從而獲得了更廣泛的接受度和需求。

隨著合成藥物在製藥業變得越來越普遍，對小原料藥等生產原料的需求預計會增加。此外，與現有產品的增強相關的技術進步有望為小分子療法提供新的機會。例如，2022年3月，贏創宣布其新穎的EUDRATEC SoluFlow技術，以增強口服小分子的溶解度。

這個市場受到各個地區政府對原料藥製造的積極支持所推動，尤其是在亞洲，那裡的大多數原料藥製造商都依賴原料藥供應來生產合成小分子原料藥 。人們對外包原料藥生產的興趣也日益濃厚。例如，2020年4月，為了應對COVID-19，Wavelength Pharmaceuticals擴大了治療重症患者所需的某些藥物的關鍵原料藥的供應，並推出了API CDMO服務。中國、印度和東南亞等新興市場提供了巨大的成長機會。

亞洲製造商專注於可大規模生產的較不複雜的分子，因此對新技術和複雜技術的投資相對較少。因此，對於歐洲、北美等其他已開發地區的製造商來說，投資高產量、低成本的技術是對沖競爭壓力的一種選擇。

市場中的主要企業正致力於合作生產強大的 API 產品。例如，2021年8月，Almac Sciences與Pila Pharma達成協議，生產高活性和選擇性小分子TRPV1拮抗劑API XEN-D0501。此外，CDMO 也在不斷發展，擴大其產能以滿足日益成長的合成藥物需求。例如，AGC Inc.於 2022 年 4 月宣布將擴大其在西班牙的合成藥物生產設施 7,500 平方米，預計該地區對合成小分子原料藥的需求將增加。

合成小分子 API 市場報告重點

  • 整體市場的成長歸因於原料需求的增加導致藥品產量的上升。
  • API 市場正在經歷重大轉變，人們越來越傾向於使用 CDMO 來大規模生產合成小分子藥物原料藥。
  • 根據製造商的數據，由於中小企業依賴商業製造外包，預計外包部分將在預測期內呈現最快的複合年成長率。
  • 根據應用，心血管疾病領域因其慢性特性和全球高盛行率而佔據市場主導地位，到 2024 年市場佔有率為 21.7%。
  • 由於主要企業的存在以及政府對加強該地區 API 製造能力的支持不斷增加，北美在 2024 年佔據了市場主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 合成小分子 API 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章合成小分子 API 市場：製造商業務分析

  • 2024 年及 2030 年製造商市場佔有率
  • 製造商細分儀表板
  • 2018 年至 2030 年製造商市場規模、預測與趨勢分析
  • 內部
  • 外包

5. 合成小分子 API 市場：應用業務分析

  • 2024 年和 2030 年應用市場佔有率
  • 應用程式細分儀表板
  • 2018 年至 2030 年按應用分類的市場規模、預測與趨勢分析
  • 心血管疾病
  • 腫瘤學
  • 中樞神經系統和神經病學
  • 整形外科
  • 外包
  • 內分泌學
  • 呼吸系統醫療設備
  • 胃腸病學
  • 腎臟科
  • 眼科
  • 其他

第6章合成小分子 API 市場：區域估計和趨勢分析、製造商和應用

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Merck &Co., Inc.
    • AbbVie, Inc.
    • Bristol-Myers Squibb Company
    • Albemarle Corporation
    • Boehringer Ingelheim International GmbH
    • Cipla, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Aurobindo Pharma
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68039-976-3

Synthetic Small Molecule API Market Growth & Trends:

The global synthetic small molecule API market size is estimated to reach USD 257.4 billion by 2030, registering a CAGR of 5.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m2 for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Synthetic Small Molecule API Market Report Highlights:

  • The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material
  • The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk
  • By manufacturer, the outsourced segment is expected to witness fastest CAGR over the forecast period, owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • By application, the cardiovascular diseases segment dominated the market in 2024 with a market share of 21.7%, owing to their chronic nature and high global prevalence.
  • North America dominated the market in 2024, due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Manufacturer
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Synthetic Small Molecule API Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Synthetic Small Molecule API Market: Manufacturer Business Analysis

  • 4.1. Manufacturer Market Share, 2024 & 2030
  • 4.2. Manufacturer Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Manufacturer, 2018 to 2030 (USD Billion)
  • 4.4. In-house
    • 4.4.1. In-house Market, 2018 - 2030 (USD Billion)
  • 4.5. Outsourced
    • 4.5.1. Outsourced Market, 2018 - 2030 (USD Billion)

Chapter 5. Synthetic Small Molecule API Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
  • 5.5. Oncology
    • 5.5.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 5.6. CNS and Neurology
    • 5.6.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
  • 5.7. Orthopedic
    • 5.7.1. Orthopedic Market, 2018 - 2030 (USD Billion)
  • 5.8. Outsourced
    • 5.8.1. Outsourced Market, 2018 - 2030 (USD Billion)
  • 5.9. Endocrinology
    • 5.9.1. Endocrinology Market, 2018 - 2030 (USD Billion)
  • 5.10. Pulmonology
    • 5.10.1. Pulmonology Market, 2018 - 2030 (USD Billion)
  • 5.11. Gastroenterology
    • 5.11.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
  • 5.12. Nephrology
    • 5.12.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 5.13. Ophthalmology
    • 5.13.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
  • 5.14. Others
    • 5.14.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Synthetic Small Molecule API Market: Regional Estimates & Trend Analysis Manufacturer and Application

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Synthetic Small Molecule API Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Billion)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. Australia Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. South Korea Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Merck & Co., Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. AbbVie, Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Bristol-Myers Squibb Company
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Albemarle Corporation
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Boehringer Ingelheim International GmbH
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Cipla, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Dr. Reddy's Laboratories Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Aurobindo Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Sun Pharmaceutical Industries Ltd.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global synthetic small molecule API market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 5 Global synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 6 North America synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 8 North America synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 9 U.S. synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 10 U.S. synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 11 Canada synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 12 Canada synthetic small molecule API market, by Application, 2018 - 2030 (USD Billion)
  • Table 13 Mexico synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 14 Mexico synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Europe synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 17 Europe synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 18 UK synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 19 UK synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 20 Germany synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 21 Germany synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 22 France synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 23 France synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 24 Italy synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 25 Italy synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 26 Spain synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 27 Spain synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Denmark synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 29 Denmark synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 30 Sweden synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Sweden synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 32 Norway synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 Norway synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 37 Japan synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 38 Japan synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 39 China synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 40 China synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 41 India synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 42 India synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 43 Australia synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 44 Australia synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 45 South Korea synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 South Korea synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 47 Thailand synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 48 Thailand synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Latin America synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 50 Latin America synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Latin America synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Brazil synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 53 Brazil synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Argentina synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 Argentina synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Middle East & Africa synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 59 South Africa synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 60 South Africa synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 63 UAE synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 64 UAE synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Synthetic small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Manufacturer and application outlook (USD Billion)
  • Fig. 9 Competitive landscape
  • Fig. 10 Synthetic small molecule API market dynamics
  • Fig. 11 Synthetic small molecule API market: Porter's five forces analysis
  • Fig. 12 Synthetic small molecule API market: PESTLE analysis
  • Fig. 13 Synthetic small molecule API market: Manufacturer segment dashboard
  • Fig. 14 Synthetic small molecule API market: Manufacturer market share analysis, 2024 & 2030
  • Fig. 15 In-house market, 2018 - 2030 (USD Billion)
  • Fig. 16 Outsourced market, 2018 - 2030 (USD Billion)
  • Fig. 17 Synthetic small molecule API market: Application segment dashboard
  • Fig. 18 Synthetic small molecule API market: Application market share analysis, 2024 & 2030
  • Fig. 19 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
  • Fig. 20 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 21 CNS and neurology market, 2018 - 2030 (USD Billion)
  • Fig. 22 Orthopedic market, 2018 - 2030 (USD Billion)
  • Fig. 23 Endocrinology market, 2018 - 2030 (USD Billion)
  • Fig. 24 Pulmonology market, 2018 - 2030 (USD Billion)
  • Fig. 25 Gastroenterology market, 2018 - 2030 (USD Billion)
  • Fig. 26 Nephrology market, 2018 - 2030 (USD Billion)
  • Fig. 27 Ophthalmology market, 2018 - 2030 (USD Billion)
  • Fig. 28 Others market, 2018 - 2030 (USD Billion)
  • Fig. 29 Synthetic small molecule API market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 44 France country dynamics
  • Fig. 45 France synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 54 Norway country dynamics
  • Fig. 55 Norway synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 59 China country dynamics
  • Fig. 60 China synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 61 India country dynamics
  • Fig. 62 India synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 74 MEA synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework